Latest News

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

110 of 215278
Signature-Vertical.png

Article ID: 714511

Major League Baseball Grant Funds Study of Pitch Counts, Throwing Injuries

Michigan Medicine - University of Michigan

A grant from Major League Baseball allows Michigan Medicine orthopaedic sports medicine researchers to examine throw counts in youth baseball players to prevent adolescent throwing arm injuries.

Released:
18-Jun-2019 11:00 AM EDT
Open in New Tab
Comment
Embargo will expire:
20-Jun-2019 12:05 AM EDT
Released to reporters:
18-Jun-2019 11:00 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 20-Jun-2019 12:05 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

hms-logo.gif
  • Embargo expired:
    18-Jun-2019 11:00 AM EDT
Released:
13-Jun-2019 3:15 PM EDT
Open in New Tab
Comment

Social and Behavioral Sciences

IDSA HIVMA Joint Logo.png

Article ID: 714518

Lower Health Care Costs Act Highlights the Value of Vaccines

Infectious Diseases Society of America (IDSA) and the HIV Medicine Association (HIVMA)

The Senate Health, Education, Labor and Pensions Committee hearing today on the Lower Health Care Costs Act provides a valuable opportunity for lawmakers to address challenges compromising access to and uptake of vaccines that are among our most important public health tools.

Released:
18-Jun-2019 10:05 AM EDT
Open in New Tab
Comment

Law and Public Policy

SJU-logo.png
Released:
18-Jun-2019 10:00 AM EDT
Open in New Tab
Comment

Pop Culture

Channels:

Arts and Entertainment

Languages:

English

Newswise: Study Shows Experimental Drug Can Encourage Bone Growth in Children with Dwarfism

Article ID: 714497

Study Shows Experimental Drug Can Encourage Bone Growth in Children with Dwarfism

Johns Hopkins Medicine

Researchers at Johns Hopkins Medicine, the Murdoch Children’s Research Institute in Australia and seven other medical institutions report that an experimental drug called vosoritide, which interferes with certain proteins that block bone growth, allowed the average annual growth rate to increase in a study of 35 children and teenagers with achondroplasia, a form of dwarfism. The patients’ average boost in height to about 6 centimeters (2.4 inches) per year is close to growth rates among children of average stature, and the side effects of the drug were mostly mild, according to the researchers.

Released:
18-Jun-2019 10:00 AM EDT
Open in New Tab
Comment
chp-logo.jpg

Article ID: 714510

Parental Support Is Key When Autistic Adolescents Want to Learn to Drive

Children's Hospital of Philadelphia

Autistic adolescents need the support of their parents or guardians to prioritize independence so that they are prepared for learning to drive, according to a study of specialized driving instructors who have worked specifically with young autistic drivers.

Released:
18-Jun-2019 9:40 AM EDT
Open in New Tab
Comment

Article ID: 714477

Clearing the Decks: MTRI Zooms in on Bridge Damage

Michigan Technological University

A hitch-mounted, cinema-quality camera on a pick-up truck can make bridge inspections safer and faster, developed by the Michigan Tech Research Institute (MTRI) and Michigan Department of Transportation (MDOT).

Released:
18-Jun-2019 9:35 AM EDT
Open in New Tab
Comment
Newswise: Researchers from Johns Hopkins Kimmel Cancer Center Successfully Pilot Multidisciplinary Approach for Addressing Immunotherapy-Related Toxicities
  • Embargo expired:
    18-Jun-2019 9:25 AM EDT

Article ID: 714476

Researchers from Johns Hopkins Kimmel Cancer Center Successfully Pilot Multidisciplinary Approach for Addressing Immunotherapy-Related Toxicities

National Comprehensive Cancer Network® (NCCN®)

New research from the Johns Hopkins Kimmel Cancer Center, published in the June 2019 issue of JNCCN—Journal of the National Comprehensive Cancer Network, pilots multidisciplinary team approach for providing diagnosis and management of immunotherapy-related adverse events (irAEs).

Released:
17-Jun-2019 3:05 PM EDT
Open in New Tab
Comment

Article ID: 714509

Intrexon Corporation and Surterra Wellness Partner in $100mm Deal to Advance Commercial Scale Fermentation-based Cannabinoid Production

Intrexon Corporation

Intrexon Corporation (Intrexon) (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve quality of life and health of the planet

Released:
18-Jun-2019 9:00 AM EDT
Open in New Tab
Comment

Showing results

110 of 215278

Chat now!